Premium
Organogenesis Holdings Inc (ORGO)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2025-01-10 | Mr. Brian GrowChief Commercial Officer | 958,00 | 1,19k | Derivative Exercise and Retained Stock | 1,24 | 483,69k | 0,20% |
| 2026-03-09 | Mr. Arthur S. LeibowitzLead Independent Director | 5,00k | 13,41k | Achat | 2,68 | 242,19k | 2,11% |
| 2026-03-09 | Dr. Michael Joseph DriscollIndependent Director | 10,00k | 26,69k | Achat | 2,67 | - | - |
| 2026-03-01 | Mr. Robert CavorsiChief Business Officer | -700,00 | 2,25k | Sale to Issuer | 3,21 | 275,52k | -0,25% |
| 2026-02-18 | Mr. Antonio S. MontecalvoInitié | -3,78k | 14,51k | Sale to Issuer | 3,84 | 107,02k | -3,41% |
| 2026-02-18 | Mr. Brian GrowChief Commercial Officer | -11,89k | 45,65k | Sale to Issuer | 3,84 | 368,56k | -3,12% |
| 2026-02-18 | Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board | -91,31k | 350,63k | Sale to Issuer | 3,84 | 2,24M | -3,91% |
| 2026-02-18 | Mr. Patrick BilboCOO | -16,38k | 62,88k | Sale to Issuer | 3,84 | 603,77k | -2,64% |
| 2026-02-18 | Mr. David C. FranciscoCFO | -14,69k | 56,40k | Sale to Issuer | 3,84 | 271,33k | -5,13% |
| 2026-02-18 | Mr. Robert CavorsiChief Business Officer | -5,49k | 21,07k | Sale to Issuer | 3,84 | 276,22k | -1,95% |
| 2026-02-18 | Ms. Lori H. FreedmanChief Administrative & Legal Officer | -14,41k | 55,34k | Sale to Issuer | 3,84 | 522,35k | -2,68% |
| 2026-02-15 | Mr. Patrick BilboCOO | -64,41k | 240,26k | Sale to Issuer | 3,73 | 571,04k | -10,14% |
| 2026-02-15 | Mr. David C. FranciscoCFO | -52,45k | 195,63k | Sale to Issuer | 3,73 | 241,98k | -17,81% |
| 2026-02-15 | Mr. Robert CavorsiChief Business Officer | -17,66k | 65,86k | Sale to Issuer | 3,73 | 171,51k | -9,33% |
| 2026-02-15 | Mr. Gary S. GillheeneyPresident, CEO, Chair of the Board | -271,41k | 1,01M | Sale to Issuer | 3,73 | 2,15M | -11,23% |
| 2026-02-15 | Ms. Lori H. FreedmanChief Administrative & Legal Officer | -54,74k | 204,19k | Sale to Issuer | 3,73 | 523,93k | -9,46% |
| 2026-02-15 | Mr. Brian GrowChief Commercial Officer | -43,96k | 163,97k | Sale to Issuer | 3,73 | 331,63k | -11,70% |
| 2026-02-15 | Mr. Antonio S. MontecalvoInitié | -18,62k | 69,45k | Sale to Issuer | 3,73 | 77,91k | -19,29% |
| 2025-12-16 | Mr. Glenn H. NussdorfDirector | -200,00k | 1,03M | Vente | 5,14 | 11,75M | -1,67% |
| 2025-11-24 | Mr. Glenn H. NussdorfDirector | -300,00k | 1,59M | Vente | 5,29 - 5,34 | 11,95M | -2,45% |
| 2025-05-14 | Mr. Glenn H. NussdorfDirector | 358,50k | 1,10M | Achat | 2,99 - 3,09 | 12,25M | 3,02% |
| 2025-06-09 | Mr. Glenn H. NussdorfDirector | -22,78k | 80,80k | Vente | 3,50 - 3,56 | 12,25M | -0,19% |
| 2025-08-11 | Mr. Brian GrowChief Commercial Officer | 1,89k | 4,66k | Derivative Exercise and Retained Stock | 2,47 | 202,42k | 0,94% |
| 2025-08-11 | Mr. Brian GrowChief Commercial Officer | -2,17k | 4,66k | Derivative Exercise and Sale | 2,47 - 4,62 | 202,42k | - |
| 2025-07-16 | Mr. Robert CavorsiChief Business Officer | -360,00 | 1,61k | Sale to Issuer | 4,47 | 189,17k | -0,19% |
| 2025-06-04 | Ms. Lori H. FreedmanChief Administrative & Legal Officer | 252,26k | 725,29k | Achat | 2,82 - 2,99 | 419,71k | 150,65% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
